Old Mutual Global Investors UK Ltd. decreased its holdings in Petmed Express Inc (NASDAQ:PETS) by 6.5% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 279,108 shares of the company’s stock after selling 19,535 shares during the period. Old Mutual Global Investors UK Ltd. owned approximately 1.35% of Petmed Express worth $12,699,000 at the end of the most recent quarter.
A number of other hedge funds have also added to or reduced their stakes in the business. Vanguard Group Inc. raised its holdings in Petmed Express by 21.0% in the 2nd quarter. Vanguard Group Inc. now owns 1,300,725 shares of the company’s stock valued at $52,810,000 after acquiring an additional 225,474 shares during the last quarter. Dimensional Fund Advisors LP grew its stake in shares of Petmed Express by 8.3% in the 2nd quarter. Dimensional Fund Advisors LP now owns 860,601 shares of the company’s stock valued at $34,940,000 after buying an additional 65,932 shares during the period. Prudential Financial Inc. grew its stake in shares of Petmed Express by 552.8% in the 3rd quarter. Prudential Financial Inc. now owns 824,434 shares of the company’s stock valued at $27,330,000 after buying an additional 698,140 shares during the period. Uniplan Investment Counsel Inc. grew its stake in shares of Petmed Express by 76.9% in the 3rd quarter. Uniplan Investment Counsel Inc. now owns 333,220 shares of the company’s stock valued at $11,046,000 after buying an additional 144,903 shares during the period. Finally, Penserra Capital Management LLC grew its stake in shares of Petmed Express by 172.7% in the 4th quarter. Penserra Capital Management LLC now owns 327,359 shares of the company’s stock valued at $14,894,000 after buying an additional 207,331 shares during the period. Institutional investors own 96.66% of the company’s stock.
Shares of Petmed Express Inc (NASDAQ:PETS) opened at $44.06 on Thursday. Petmed Express Inc has a one year low of $19.21 and a one year high of $57.80. The firm has a market cap of $900.06, a P/E ratio of 25.85, a PEG ratio of 2.57 and a beta of 0.95.
Petmed Express (NASDAQ:PETS) last posted its quarterly earnings results on Monday, January 22nd. The company reported $0.44 earnings per share for the quarter, beating the consensus estimate of $0.33 by $0.11. Petmed Express had a net margin of 12.84% and a return on equity of 34.04%. The business had revenue of $60.10 million during the quarter, compared to analysts’ expectations of $56.76 million. During the same quarter in the prior year, the company posted $0.24 EPS. The business’s revenue for the quarter was up 13.6% on a year-over-year basis. analysts anticipate that Petmed Express Inc will post 1.7 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 16th. Investors of record on Monday, February 5th will be given a dividend of $0.25 per share. The ex-dividend date of this dividend is Friday, February 2nd. This represents a $1.00 dividend on an annualized basis and a dividend yield of 2.27%. This is a boost from Petmed Express’s previous quarterly dividend of $0.20. Petmed Express’s dividend payout ratio (DPR) is presently 59.17%.
PETS has been the subject of several analyst reports. Noble Financial reissued a “hold” rating on shares of Petmed Express in a research note on Friday, October 27th. Zacks Investment Research raised shares of Petmed Express from a “sell” rating to a “hold” rating and set a $50.00 price target for the company in a research note on Friday, October 20th. BidaskClub cut shares of Petmed Express from a “strong-buy” rating to a “buy” rating in a research note on Friday, January 19th. Northcoast Research set a $58.00 price target on shares of Petmed Express and gave the company a “buy” rating in a research note on Wednesday, January 3rd. Finally, ValuEngine raised shares of Petmed Express from a “hold” rating to a “buy” rating in a research note on Wednesday, February 7th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and four have issued a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus price target of $42.80.
In related news, CEO Menderes Akdag sold 30,000 shares of the stock in a transaction that occurred on Thursday, January 11th. The shares were sold at an average price of $51.00, for a total transaction of $1,530,000.00. Following the completion of the transaction, the chief executive officer now owns 490,000 shares of the company’s stock, valued at approximately $24,990,000. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Gian Fulgoni sold 20,000 shares of the stock in a transaction that occurred on Friday, December 15th. The stock was sold at an average price of $44.38, for a total transaction of $887,600.00. Following the transaction, the director now directly owns 55,900 shares of the company’s stock, valued at approximately $2,480,842. The disclosure for this sale can be found here. Insiders have sold a total of 65,000 shares of company stock valued at $3,229,500 in the last ninety days. 4.00% of the stock is currently owned by corporate insiders.
COPYRIGHT VIOLATION WARNING: “Old Mutual Global Investors UK Ltd. Sells 19,535 Shares of Petmed Express Inc (PETS)” was first published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this piece of content on another site, it was illegally stolen and reposted in violation of US and international copyright and trademark laws. The original version of this piece of content can be read at https://www.dispatchtribunal.com/2018/02/15/old-mutual-global-investors-uk-ltd-sells-19535-shares-of-petmed-express-inc-pets.html.
Petmed Express Profile
PetMed Express, Inc (PetMed Express), doing business as 1800PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. It offers a selection of products for dogs and cats. Its product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies.
Want to see what other hedge funds are holding PETS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Petmed Express Inc (NASDAQ:PETS).
Receive News & Ratings for Petmed Express Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Petmed Express and related companies with MarketBeat.com's FREE daily email newsletter.